OCT-461201 by Oxford Cannabinoid Technologies for Visceral Pain: Likelihood of Approval
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and currently in Phase I for Visceral Pain.
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and currently in Phase I for Visceral Pain.
What's Your Reaction?
